Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2-Specific Immune Responses

被引:12
作者
Kim, Kyun-Do [1 ]
Hwang, Insu [1 ]
Ku, Keun Bon [1 ]
Lee, Sumin [1 ]
Kim, Seong-Jun [1 ]
Kim, Chonsaeng [1 ]
机构
[1] Korea Res Inst Chem Technol, Ctr Convergent Res Emerging Virus Infect, Daejeon 34114, South Korea
关键词
COVID-19; SARS-CoV-2; Coronavirus; vaccine; immune response; RESPIRATORY-SYNDROME-CORONAVIRUS; NEUTRALIZING ANTIBODIES; INFLAMMATORY CYTOKINES; SARS; ACTIVATION; RECEPTORS; INFECTION; SPIKE; INTERFERON; EXPRESSION;
D O I
10.4014/jmb.2006.06006
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading globally, and the WHO has declared this outbreak a pandemic. Vaccines are an effective way to prevent the rapid spread of COVID-19. Furthermore, the immune response against SARS-CoV-2 infection needs to be understood for the development of an efficient and safe vaccine. Here, we review the current understanding of vaccine targets and the status of vaccine development for COVID-19. We also describe host immune responses to highly pathogenic human coronaviruses in terms of innate and adaptive immunities.
引用
收藏
页码:1109 / 1115
页数:7
相关论文
共 69 条
  • [1] Recombinant adenoviral vaccine encoding the spike 1 subunit of the Middle East Respiratory Syndrome Coronavirus elicits strong humoral and cellular immune responses in mice
    Ababneh, Mustafa
    Alrwashdeh, Mu'men
    Khalifeh, Mohammad
    [J]. VETERINARY WORLD, 2019, 12 (10) : 1554 - 1562
  • [2] Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
    Ahmed, Syed Faraz
    Quadeer, Ahmed A.
    McKay, Matthew R.
    [J]. VIRUSES-BASEL, 2020, 12 (03):
  • [3] [Anonymous], 2020, MMWR MORBID MORTAL W
  • [4] Virus-induced double-membrane vesicles
    Blanchard, Emmanuelle
    Roingeard, Philippe
    [J]. CELLULAR MICROBIOLOGY, 2015, 17 (01) : 45 - 50
  • [5] Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease
    Chan, Jasper F. W.
    Lau, Susanna K. P.
    To, Kelvin K. W.
    Cheng, Vincent C. C.
    Woo, Patrick C. Y.
    Yuen, Kwok-Yung
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2015, 28 (02) : 465 - 522
  • [6] Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
    Channappanavar, Rudragouda
    Fehr, Anthony R.
    Vijay, Rahul
    Mack, Matthias
    Zhao, Jincun
    Meyerholz, David K.
    Perlman, Stanley
    [J]. CELL HOST & MICROBE, 2016, 19 (02) : 181 - 193
  • [7] Clinical progression of patients with COVID-19 in Shanghai, China
    Chen, Jun
    Qi, Tangkai
    Liu, Li
    Ling, Yun
    Qian, Zhiping
    Li, Tao
    Li, Feng
    Xu, Qingnian
    Zhang, Yuyi
    Xu, Shuibao
    Song, Zhigang
    Zeng, Yigang
    Shen, Yinzhong
    Shi, Yuxin
    Zhu, Tongyu
    Lu, Hongzhou
    [J]. JOURNAL OF INFECTION, 2020, 80 (05) : E1 - E6
  • [8] Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11
    Cheng, M
    Chan, CWL
    Cheung, RCF
    Bikkavilli, RK
    Zhao, Q
    Au, SWN
    Chan, PKS
    Lee, SST
    Cheng, G
    Ho, WKK
    Cheung, WT
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 338 (03) : 1654 - 1660
  • [9] Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection
    Cheng, Vincent C. C.
    Lau, Susanna K. P.
    Woo, Patrick C. Y.
    Yuen, Kwok Yung
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2007, 20 (04) : 660 - +
  • [10] Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
    Coleman, Christopher M.
    Liu, Ye V.
    Mu, Haiyan
    Taylor, Justin K.
    Massare, Michael
    Flyer, David C.
    Glenn, Gregory M.
    Smith, Gale E.
    Frieman, Matthew B.
    [J]. VACCINE, 2014, 32 (26) : 3169 - 3174